Stock Market News2 months 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks
Here, we discuss four biotech stocks, ADMA, TARS, STOK and CDXC, which have returned more than 50% year to date and have room for more growth in 2025.
XHere, we discuss four biotech stocks, ADMA, TARS, STOK and CDXC, which have returned more than 50% year to date and have room for more growth in 2025.
X